Cargando…
Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice
Purpose: Tumor vascular targeting appeared as an appealing approach to fight cancer, though, the results from the clinical trials and drugs in the market were proved otherwise. The promise of anti-angiogenic therapy as the leading tumor vascular targeting strategy was negatively affected with the di...
Autores principales: | Daei Farshchi Adli, Amir, Jahanban-Esfahlan, Rana, Seidi, Khaled, Farajzadeh, Davoud, Behzadi, Ramezan, Zarghami, Nosratollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046391/ https://www.ncbi.nlm.nih.gov/pubmed/33880362 http://dx.doi.org/10.34172/apb.2021.037 |
Ejemplares similares
-
NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
por: Seidi, Khaled, et al.
Publicado: (2018) -
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice
por: Jahanban-Esfahlan, Rana, et al.
Publicado: (2017) -
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
por: Jahanban-Esfahlan, Rana, et al.
Publicado: (2019) -
Static DNA Nanostructures For Cancer Theranostics: Recent Progress In Design And Applications
por: Jahanban-Esfahlan, Rana, et al.
Publicado: (2019) -
Isothermal Amplification of Nucleic Acids Coupled with Nanotechnology and Microfluidic Platforms for Detecting Antimicrobial Drug Resistance and Beyond
por: Alamolhoda, Seyedeh Zahra, et al.
Publicado: (2022)